Loading market dashboard
Xcelerate Inc.
XCRTHealthcareOTCUS
Loading disclosure news
News and disclosures filtered by period, publisher, and event group.
Select a headline to open the full news page in the app.
XCELERATE ANNOUNCES AGREEMENTS WITH TANZANIAN MEDICAL PROFESSIONALS TO BEGIN LOCAL OPERATIONS Agreement with Dr. Desire Ruhinda will allow the Company to move forward with its pilot program MAULDIN, SC / ACCESS Newswire / May 4, 2026 / Xcelerate Inc. (OTCQB:XCRT) today announced that its majority-owned subsidiary, AfiyaSasa Africa LLC, has entered into a consulting agreement with Tanzanian medical doctor Dr. Desire Ruhinda to support the next phase of the Company's AfiyaSasa Africa initiative, while also confirming a May on-site R&D engagement led by its Chief Science Officer, Dr. Anja Glisovic. The agreement with Dr. Ruhinda marks a transition from strategic planning to operational execution of the Company's previously announced initiative to evaluate artificial intelligence-enabled healthcare delivery models in underserved markets.
Xcelerate, Inc. (OTCMKTS:XCRT - Get Free Report) was the target of a large increase in short interest in the month of April. As of April 15th, there was short interest totaling 45,438 shares, an increase of 80.0% from the March 31st total of 25,240 shares. Based on an average trading volume of 100,805 shares, the
Xcelerate, Inc. (OTCMKTS:XCRT - Get Free Report) saw a large growth in short interest during the month of March. As of March 13th, there was short interest totaling 26,637 shares, a growth of 60.0% from the February 26th total of 16,648 shares. Based on an average daily volume of 88,908 shares, the days-to-cover ratio is
